EPISODE · May 27, 2023 · 15 MIN
Wegovy’s So-Called “Long-Term” Study
from Weight and Healthcare · host Ragen Chastain
Today we are breaking down Novo Nordisk's 2-year study of their weight loss drug, Wegovy. I want to thank Deb Burgard for her help with this piece. She is quoted and was kind enough to review and give feedback on the piece and I am incredibly grateful! Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe
Embed this episode
NOW PLAYING
Wegovy’s So-Called “Long-Term” Study
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.